Brazil Regulator Approves Ultrapar’s Unit Sale to Indorama

General Superintendence of Brazil antitrust regulator recommended the approval without restrictions of Oxiteno sale to Indorama Ventures, Ultrapar said in a filing.

• As long as there are no third-party appeals or appeal by regulator court, the decision will become final within 15 days
• Closing of the transaction must occur after this period and under the conditions provided for in the contract
• NOTE: Indorama to Buy Ultrapar’s Chemicals Unit for $1.3 Billion (1)

To see the source of this information click on here

Original Story:

Ultrapar: Cade aprovou venda da Oxiteno para Indorama Ventures

To contact the translator on this story: ...